Since Valneva was founded in 2013, it has participated in 12 rounds of funding. In total Valneva has raised $580.3M. Valneva's last funding round was on Jul 2024 for a total of $41.3M.
Valneva has 8 investors, including The Coalition for Epidemic Preparedness Innovations, the european union and Pfizer Inc.. The latest investment occurred in Jul 2024.
